期刊文献+

双歧杆菌片口服预防小儿肺炎继发腹泻探讨 被引量:3

Live combined birfidobacterium protection in diarrhea of children with pneumonia
下载PDF
导出
摘要 目的 探讨双歧杆菌片口服预防小儿肺炎继发腹泻效果。方法2004年1月~2006年12月在我院儿科治疗的小儿肺炎138例,以住院期间抗生素治疗同时应用双歧杆菌片的58例患儿为病例组;仅使用抗生素治疗或住院72h后因出现继发腹泻才开始应用双歧杆菌片的80例患儿为对照组,对肺炎继发腹泻的发生率与双歧杆菌应用情况进行统计学分析。结果病例组58例,住院治疗期间继发腹泻10例,发生率为17.2%;对照组80例,继发腹泻33例,发生率为41.3%。卡方分析显示,两组比较差异有统计学意义(χ^2=6.2767,P〈0.05)。结论使用抗生素同时应用双歧杆菌片能够降低小儿肺炎继发腹泻发生率。 Objective To assess the efficacy of Birfidobacterium in diarrhea in children with pneumonia who treated in hospital over 3 days. Methods A total of 138 children with pneumonia were reviewed from Jan. 2004 to Dec. 2006. The case group were treated with use of Birfidobacterium and the control group were treated without Birfidobacterium because of diarrhea 3days later. Results The morbidity was 17.2 % in case group, and 41.3 % in the control group. Conclusion Birfidobacterium may be used to reduce the morbidity of diarrhea of children with pneumonia.
作者 陈静
出处 《四川医学》 CAS 2008年第1期58-59,共2页 Sichuan Medical Journal
关键词 肺炎 双歧杆菌 儿童 pneumonia diarrhea birfidobacterium children
  • 相关文献

参考文献4

二级参考文献23

  • 1Hogenauer C, Hammer HF, Krejs GJ, et al. Mechanisms and mana gement of antibiotic-associated diarrhea[J]. Clin Infect Dis, 1998,27(4):702 - 710.
  • 2Mitchell DK, Van R, Mason EH, et al. Prospective study of toxigenic Clostridium difficile in children given amoxicillin/clavulanate for otitis media[J]. Pediatr Infect Dis J, 1996,15(6):514-519.
  • 3Wilcox M, Minton J. Role of antibody response in outcome of antibiotic - associated diarrhea[J]. Lancet, 2001,357(9251):158 - 159.
  • 4Cerquetti M, Luzzi I, Caprioli A, et al. Role of Clostridium difficile in childhood diarrhea[J]. Pediatr Infect Dis, J 1995,14(7):598-603.
  • 5Tina LG, Proto N, Sciacca A. Assmptomatic intestinal colonization by Clostridium difficile in preterm neonates[J]. Pediatr Infect Dis J,1994, 13(12):1158 - 1159.
  • 6Wistrom J, Norrby SR, Myhre EB, et al. Frequency of antibiotic associated diarrhea in 2462 antibiotic- treated hospitalized patients: a prospective study[J]. J Antimicrob Chemother, 2001,47(4):43-50.
  • 7Cheng SH, Lu JJ, Young TG, et al. Clostridium difficile- associated diseases: comparison of symptomatic infection versus carriage on the basis of risk factors, toxin production, and genotyping results[J]. Clin Infect Dis, 1997,25(1):157 - 158.
  • 8Fekety R. Guidelines for the diagnosis and management of Clostridium difficile - associated diarrhea and colitis[J]. Am J Gastroenterol, 1997.92(5):739 - 750.
  • 9Brazier JS. The diagnosis of Clostridium difficile- associated disease[J]. J Antimicrob Chemother. 1998,41(Suppl C):29-40.
  • 10Ludlam H, Brown N, Sule O, et al. An antibiotic policy associated with reduced risk of Clostridium difficile-associated diarrhea[J]. Age Ageing, 1999,28(6):578 - 580.

共引文献199

同被引文献87

引证文献3

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部